Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
A method is described to amplify the delivery of 111In to human breast cancer cells utilizing a novel human serum albumin-human EGF (HSA-hEGF) bioconjugate substituted preferentially in the HSA domain with multiple DTPA metal chelators for 111In. 111In-DTPA-HSA-hEGF exhibited a lower receptor-bindin...
Hlavní autoři: | Wang, J, Chen, P, Su, Z, Vallis, K, Sandhu, J, Cameron, R, Hendler, A, Reilly, R |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2001
|
Podobné jednotky
-
Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
Autor: Chen, P, a další
Vydáno: (2002) -
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
Autor: Reilly, R, a další
Vydáno: (2000) -
In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
Autor: Reilly, R, a další
Vydáno: (2000) -
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Autor: Reilly, R, a další
Vydáno: (2000) -
The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
Autor: Chen, P, a další
Vydáno: (2001)